| Alternative name 1: |
B-Cell, Clone: F8-11-13, Mab anti-Human, Monocyte, PE, T-Cell (subset), gp220, CD45RA |
| Alternative name 2: |
B-Cell, Clone: F8-11-13, Mab antibody-Human, Monocyte, PE, T-Cell (subset), gp220, CD45RA |
| Alternative name 3: |
B-Cell, Clone: F8-11-13, Mab antibody-Homo sapiens, Monocyte, PE, T-Cell (subset), gp220, CD45RA |
| Alternative name 4: |
anti-CD45RA B-Cell Monocyte T-Cell subset gp220 Clone: F8-11-13 |
| Alternative name 5: |
CD45RA B-Cell Monocyte T-Cell subset gp220 Clone: F8-11-13 |
| Clonality: |
Monoclonal Antibody |
| Description: |
Amongst the advantages of the monoclonal antibodies are: the fact that while the hybridoma takes a bit longer to be produced, If used correctly and according the protocol, in comparison to the polyclonal antibodies monoclonal antibodies are highly specific to a given epitope and can be used in applications where specific targeting is required, once the line is ready there is virtually an endless supply of these antibodie throughout time with little to no variations in recognition sites of the antigen in different batches, this antibody will provide excellent and reproducible results with guaranteed success for the tested and confirmed applications, This is a monoclonal antibody which is greatly purified and with high binding affinity for the antigen that it is risen against |
| Storage and handling: |
Antibodies in a liquid form can be shipped and stored for a short period of time at +4 degrees Celsius, antibodies that are lyophilized can be transported at ambient temperature and stored for short terms at +4 degrees Celsius, for long term storage (up to one year) 25-50% glycerol or ethylene glycol should be added and then the container has to be stored at -20°, for longer periods - at -20 , C, Generally |
| Advisory: |
For antibodies in a liquid form or reconstituted lyophilized antibodies small amounts of the soultion could be captured on the cap or the walls of the container, Right before use you could briefly centrifuge the vial to collect all of the solution on the bottom, To keep the quality and the affinity of the antibody cycles of freezing and thawing should be avoided |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| About: |
Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones |
| Test: |
A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or |
| Latin name: |
Mus musculus |
| French translation: |
anticorps |
| Gene target: |
B Monocyte, F8-11-13, Monoclonal PE, T (subset) gp220, CD45RA |
| Short name: |
B-Cell, Clone: F8-11-13, Monocyte, Mouse Monoclonal antibody- PE, T-Cell (subset) gp220, CD45RA |
| Technique: |
Monoclonals or monoclonal antibodies, mouses, Mouse |
| Label: |
PE |
| Species: |
Humans, Mouses, Human |
| Alternative name: |
B-cellular, Monocyte, Mouse monoclonal (Antibody to)-H, T-cellular (subset), clonality: coagulation factor VIII, gp220, peroxidase, procoagulant component-11-13, sapiens, CD45RA |
| Alternative technique: |
murine |
| Alternative to gene target: |
AHF and DXS1253E and F8B and F8C and FVIII and HEMA, Extracellular, F8 and IDBG-157124 and ENSMUSG00000031196 and 14069, F8 and IDBG-632125 and ENSBTAG00000010726 and 100271720, F8 and IDBG-92134 and ENSG00000185010 and 2157, intrinsic pathway and biological process this GO :0016491 and oxidoreductase activity and molecular function this GO :0030168 and platelet activation and biological process this GO :0031093 and platelet alpha granule lumen and cellular component this GO :0055114 and oxidation-reduction process and biological process, oxidoreductase activity, procoagulant component, this GO :0002576 and platelet degranulation and biological process this GO :0004252 and serine-type endopeptidase activity and molecular function this GO :0005507 and copper ion binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006508 and proteolysis and biological process this GO :0006953 and acute-phase response and biological process this GO :0007155 and cell adhesion and biological process this GO :0007596 and blood coagulation and biological process this GO :0007597 and blood coagulation, this GO :0004252 : serine-type endopeptidase activity, this GO :0004252 : serine-type endopeptidase activity and also this GO :0005507 : copper ion binding and also this GO :0005515 : protein binding and also this GO :0016491 : oxidoreductase activity, this GO :0005507 : copper ion binding, this GO :0005515 : protein binding, this GO :0016491 : oxidoreductase activity, coagulation factor VIII |